logo
Select company
Select metric
$ 381.35KDepreciation, Amortization & Accretion
VS
Market
13
Sector
25
Industry
35
History
100
$ 4.15Close
$ 3.28 - $ 45.6 52-Week Range
Ticker Information

Ticker

CDIO

Company Name

CARDIO DIAGNOSTICS HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARDIO DIAGNOSTICS HOLDINGS INC - Depreciation, Amortization & Accretion Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CDIO - DepAmor Historical data
DateDepreciation, Amortization & Accretion
6/30/2025$ 381.35K
3/31/2025$ 373.33K
12/31/2024$ 276.35K
9/30/2024$ 253.79K
6/30/2024$ 211.5K
3/31/2024$ 135.17K
12/31/2023$ 111.62K
9/30/2023$ 53.8K
6/30/2023$ 17.58K
12/31/2022$ 16K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARDIO DIAGNOSTICS HOLDINGS INC's latest trailing twelve months (TTM) DepAmor stands at $ 8K.
  • Over the past 5 years, CARDIO DIAGNOSTICS HOLDINGS INC's average DepAmor has been $ 167.14K.
  • The median DepAmor for CARDIO DIAGNOSTICS HOLDINGS INC during this period was $ 135.17K
  • CARDIO DIAGNOSTICS HOLDINGS INC reached its highest DepAmor over the past 5 years at $ 381.35K.
  • The lowest DepAmor recorded by CARDIO DIAGNOSTICS HOLDINGS INC in the same timeframe $ 8K

CARDIO DIAGNOSTICS HOLDINGS INC's DepAmor vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

DepAmor Benchmarks
CompanyDepAmor
ADTX : ADITXT INC $ 452.62KIBO : IMPACT BIOMEDICAL INC $ 1.13MCELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC $ 113.23KACXP : ACURX PHARMACEUTICALS INC $ 0APVO : APTEVO THERAPEUTICS INC $ 265KPMCB : PHARMACYTE BIOTECH INC $ 0GNPX : GENPREX INC $ 1.74KALZN : ALZAMEND NEURO INC $ 65.74KPALI : PALISADE BIO INC $ 123KTCRT : ALAUNOS THERAPEUTICS INC $ -1K

Definition of Depreciation, Amortization & Accretion

[Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.

CDIO - Depreciation, Amortization & Accretion, Last 5 years

$ 8K

Minimum

Jun 30, 2022

$ 381.35K

Maximum

Jun 30, 2025

$ 167.14K

Average

$ 135.17K

Median

DepAmor Benchmark Analysis

The chart above depicts the distribution of DepAmor for companies in the Total Stock Market. The average DepAmor of the companies is $ 24.27M with a standard deviation of $ 33.87M.
The following table provides additional summary stats:
DepAmor in the Market:
filtered constituents3.16K
min$ -81M
max$ 136.98M
average$ 24.27M
median$ 6.85M
std$ 33.87M